Clinical Trial Update: Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating quality of life and survival with MS-20 in patients with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• MS-20

Snippet

Sponsor: Microbio Co Ltd | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN